Cargando…
Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
In this letter, we discuss the potential interactions of remdesivir, the newly approved Covid-19 drug with pulmonary medications. These interactions have been summarized keeping the busy clinician in mind. While remdesivir has proven to be a safe medication generally, we here have enlisted the poten...
Autores principales: | Gandhi, Zainab, Mansuri, Zeeshan, Bansod, Snehal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441835/ https://www.ncbi.nlm.nih.gov/pubmed/32864571 http://dx.doi.org/10.1007/s42399-020-00462-2 |
Ejemplares similares
-
Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
por: Patel, Dimple, et al.
Publicado: (2023) -
Prevalence of Pulmonary Embolism in COVID-19: a Pooled Analysis
por: Desai, Rupak, et al.
Publicado: (2020) -
Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021) -
Stewardship of Remdesivir Use in a Rural Community Hospital During the COVID-19 Pandemic
por: Tirupathi, Raghavendra, et al.
Publicado: (2021) -
Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)